By comparing IC50 levels of chemotherapy drugs between the two groups, we found that patients in the low-score group exhibited lower IC50 values for anti-cancer drugs, including BIRB.0796, A.443654, ABT.888, AKT.inhibitor.VIII, ATRA, and BIBW2992. Here, AKT1 is linked to cancer.